Results 371 to 380 of about 2,389,262 (402)

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-vornhagen, Victoria Metaxa, Elie Azoulay   +2 more
exaly  

Activation mechanism of endothelin ETB receptor by endothelin-1

Nature, 2016
W. Shihoya, T. Nishizawa, Akiko Okuta, K. Tani, N. Dohmae, Y. Fujiyoshi, O. Nureki, T. Doi   +7 more
semanticscholar   +1 more source

Endothelin Receptors and Ligands

1999
The discovery of endothelin led to a huge body of research, much of it aimed at elucidating the receptors through which the endothelins act. Clearly, it was reasoned, the ability to antagonise the effects of such a powerful vasoconstrictor could be of potential benefit in a number of disease states.
openaire   +2 more sources

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Rujul H Parikh
exaly  

X-ray structures of endothelin ETB receptor bound to clinical antagonist bosentan and its analog

Nature Structural &Molecular Biology, 2017
W. Shihoya, T. Nishizawa, K. Yamashita, A. Inoue, K. Hirata, Francois Marie Ngako Kadji, Akiko Okuta, K. Tani, J. Aoki, Y. Fujiyoshi, T. Doi, O. Nureki   +11 more
semanticscholar   +1 more source

Clinical Pharmacology of Endothelin Receptor Antagonists Used in the Treatment of Pulmonary Arterial Hypertension

American Journal of Cardiovascular Drugs, 2015
M. Chaumais, C. Guignabert, L. Savale, X. Jaïs, A. Boucly, D. Montani, G. Simonneau, M. Humbert, O. Sitbon   +8 more
semanticscholar   +1 more source

Endothelin‐receptor antagonists for diabetic nephropathy: A meta‐analysis

Nephrology, 2015
Wen-ming Yuan, Yi Li, J. Wang, Jing Li, Shen-Ju Gou, P. Fu   +5 more
semanticscholar   +1 more source

Efficacy, safety and clinical pharmacology of macitentan in comparison to other endothelin receptor antagonists in the treatment of pulmonary arterial hypertension

Expert Opinion on Drug Safety, 2014
J. Dingemanse, P. Sidharta, W. Maddrey, L. Rubin, Hani Mickail   +4 more
semanticscholar   +1 more source

Safety, tolerability, pharmacokinetics, and pharmacodynamics of macitentan, an endothelin receptor antagonist, in an ascending multiple‐dose study in healthy subjects

Journal of clinical pharmacology, 2013
P. Sidharta, P. V. van Giersbergen, J. Dingemanse   +2 more
semanticscholar   +1 more source

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly